ROCKWELL MEDICAL, INC. Operating Income Loss

• ROCKWELL MEDICAL, INC. showed a decrease of -871.5% in Operating Income Loss from 2024 to 2025.
• This data is from ROCKWELL MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), ROCKWELL MEDICAL, INC.'s Operating Income Loss has grown by 14.4%.
• Historical annual values: Fiscal year 2025: -$4.69 million | Fiscal year 2024: $608.0 thousand | Fiscal year 2023: -$6.67 million | Fiscal year 2022: -$16.78 million | Fiscal year 2021: -$30.34 million | Fiscal year 2020: -$28.42 million | Fiscal year 2019: -$34.53 million | Fiscal year 2018: -$32.44 million | Fiscal year 2017: -$25.92 million | Fiscal year 2016: -$20.21 million | Fiscal year 2015: -$15.10 million | Fiscal year 2014: -$17.56 million | Fiscal year 2013: -$47.06 million | Fiscal year 2012: -$54.26 million | Fiscal year 2011: -$21.68 million | Fiscal year 2010: -$2.87 million | Fiscal year 2009: -$5.48 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026